Abbott Labs’ surprise guidance bump is a major positive for investors

Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising its full-year guidance — a show of confidence by the medical device maker not seen in a first quarter since 2016. Revenue for the three months ended March 31 rose slightly more than 2% year over year to $9.96 billion, … Read more

Top 15 companies to work for in Singapore in 2024

These are the top companies to work for in Singapore in 2024, according to LinkedIn. Carlina Teteris | Moment | Getty Images Banks dominated the top 5 best companies in Singapore to work for, according to LinkedIn’s list on the best workplaces in the country in 2024. “Commercial banking firms from banking to insurance and … Read more

Stocks give up gains, but busy earnings week is good news for investors

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.) Markets wobbly: After a weak attempt … Read more

Why stocks sold off Tuesday and how investors can decide when to buy

We knew Tuesday’s selloff was coming. Not because we’re fortunate tellers but because that’s what always happens after a period of strength. We didn’t know exactly when it would happen. Nobody ever does. But we knew that as the strength continued to build in the market, we had to be ready. For some, that means … Read more

AI catalysts ahead that could boost Alphabet and Apple — and 3 quick stock takes

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.) Taking a breather: Stocks were mixed … Read more

We’re buying more of this health-care company amid an overdone sell-off

Shortly after the opening bell, we will be buying 140 shares of Abbott Laboratories at roughly $112. Following the trade, Jim Cramer’s Charitable Trust will own 700 shares of ABT, increasing our weighting in the portfolio to 2.42% from 1.95%. We are buying more Abbott Laboratories into its recent weakness as we continue to believe … Read more

Nvidia stomps the bears. Jim Cramer on struggling stocks Starbucks, Abbott

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.) Markets rebound as Nvidia goes green: … Read more

It’s not too late to buy Abbott stock after Friday selloff

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. U.S. stocks jumped Monday as the Nasdaq and S & P 500 attempts to recover from back-to-back weekly losses. Major gains were seen in tech stocks to start the new … Read more

Here is Eli Lilly’s competitive edge in GLP-1 obesity drugs and Abbott’s secondary play

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.) Inflation relief: The stock market was … Read more

Fed’s favorite inflation gauge looms next week — plus, 2 portfolio earnings reports

Wall Street returned to its winning ways this week — and Nvidia ‘s blowout earnings report Wednesday night was a big reason why. All three major U.S. stock benchmarks closed the holiday-shortened week higher, led by the S & P 500 , which rose 1.66% and ended Friday at a record high. The tech-heavy Nasdaq … Read more